{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T16:50:26Z","timestamp":1696783826026},"reference-count":37,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.molimm.2014.01.012","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T05:11:50Z","timestamp":1391836310000},"page":"91-99","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model"],"prefix":"10.1016","volume":"59","author":[{"given":"Shivakiran S.","family":"Makam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murali S.","family":"Harischandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harsh V.","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.molimm.2014.01.012_bib0005","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/IAI.73.6.3408-3414.2005","article-title":"Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines","volume":"73","author":"Aulinger","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.01.012_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0928-8244(03)00085-3","article-title":"Characterization of the immune response to the UK human anthrax vaccine","volume":"36","author":"Baillie","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"11","key":"10.1016\/j.molimm.2014.01.012_bib0015","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1128\/IAI.00884-07","article-title":"Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen","volume":"75","author":"Brahmbhatt","year":"2007","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.molimm.2014.01.012_bib0020","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/IAI.67.2.964-967.1999","article-title":"Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen","volume":"67","author":"Brossier","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.01.012_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2004.05.029","article-title":"Anthrax capsule vaccine protects against experimental infection","volume":"23","author":"Chabot","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2014.01.012_bib0030","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2007.01.068","article-title":"Immunogenicity of a subunit vaccine against Bacillus anthracis","volume":"25","author":"Chichester","year":"2007","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.molimm.2014.01.012_bib0035","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/IAI.68.8.4549-4558.2000","article-title":"Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax","volume":"68","author":"Cohen","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.01.012_bib0175","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.micpath.2005.02.001","article-title":"The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions","volume":"38","author":"Cote","year":"2005","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.molimm.2014.01.012_bib0040","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1099\/mic.0.2007\/008292-0","article-title":"Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization","volume":"154","author":"Cote","year":"2008","journal-title":"Microbiology"},{"key":"10.1016\/j.molimm.2014.01.012_bib0045","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.micinf.2011.07.005","article-title":"Key aspects of the molecular and cellular basis of inhalational anthrax","volume":"13","author":"Cote","year":"2011","journal-title":"Microbes Infect."},{"key":"10.1016\/j.molimm.2014.01.012_bib0050","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1099\/jmm.0.045393-0","article-title":"Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia","volume":"61","author":"Cote","year":"2012","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0055","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1099\/mic.0.28788-0","article-title":"Significant passive protection effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids","volume":"152","author":"Enkhtuya","year":"2006","journal-title":"Microbiology"},{"issue":"3","key":"10.1016\/j.molimm.2014.01.012_bib0060","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1128\/AEM.64.3.982-991.1998","article-title":"Fermentation, purification, characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis","volume":"64","author":"Farchaus","year":"1998","journal-title":"Appl. Environ. Microbiol."},{"issue":"4","key":"10.1016\/j.molimm.2014.01.012_bib0065","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.01.012_bib0070","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.mam.2009.07.001","article-title":"The surface of Bacillus anthracis","volume":"30","author":"Fouet","year":"2009","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.molimm.2014.01.012_bib0075","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1016\/j.vaccine.2011.03.082","article-title":"A plant based protective antigen [PA (dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax","volume":"29","author":"Gorantala","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2014.01.012_bib0080","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.molimm.2008.12.031","article-title":"Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis","volume":"46","author":"Kaur","year":"2009","journal-title":"Mol. Immunol."},{"issue":"11","key":"10.1016\/j.molimm.2014.01.012_bib0085","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1128\/IAI.00117-09","article-title":"Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen","volume":"77","author":"Kelly-Cirino","year":"2009","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.molimm.2014.01.012_bib0180","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1128\/IAI.73.12.8266-8274.2005","article-title":"Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge","volume":"73","author":"Koya","year":"2005","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.molimm.2014.01.012_bib0090","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s11274-013-1406-1","article-title":"Immunocapture PCR for rapid and sensitive detection of pathogenic Bacillus anthracis","volume":"29","author":"Makam","year":"2013","journal-title":"World J. Microbiol. Biotechnol."},{"issue":"17","key":"10.1016\/j.molimm.2014.01.012_bib0095","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1093\/emboj\/19.17.4473","article-title":"Bacterial SLH domain proteins are non-covalently anchored to the cell surface via a conserved mechanism involving wall polysaccharide pyruvylation","volume":"19","author":"Mesnage","year":"2000","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.molimm.2014.01.012_bib0100","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1128\/IAI.74.2.1009-1015.2006","article-title":"Cytokine response and survival of mice immunized with an adenovirus expressing Bacillus anthracis protective antigen domain 4","volume":"74","author":"McConnell","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.01.012_bib0105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.molimm.2014.01.012_bib0110","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/IAI.01722-07","article-title":"Enhancement of antibody to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant","volume":"76","author":"Park","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2014.01.012_bib0115","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.1834478100","article-title":"A dually active anthrax vaccine that confers protection against both bacilli and toxins","volume":"100","author":"Rhie","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2014.01.012_bib0120","doi-asserted-by":"crossref","first-page":"8945","DOI":"10.1073\/pnas.1633512100","article-title":"Poly (gamma-d-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine","volume":"100","author":"Schneerson","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2014.01.012_bib0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1574-695X.2007.00347.x","article-title":"Nasal immunization with the mixture of PA63 LF, and aPGA conjugate induced strong antibody responses against all three antigens","volume":"52","author":"Sloat","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0185","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0168-1656(95)00092-5","article-title":"Development of novel vaccines against anthrax in man","volume":"44","author":"Stepanov","year":"1996","journal-title":"J Biotechnol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0130","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2012.04.007","article-title":"Protective effect of Bacillus anthracis surface protein EA1 against anthrax in mice","volume":"421","author":"Uchida","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.molimm.2014.01.012_bib0135","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","article-title":"Identification of a receptor binding region within domain 4 of the protective antigen component of anthrax toxin","volume":"67","author":"Varughese","year":"1999","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.molimm.2014.01.012_bib0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1128\/CVI.00550-12","article-title":"Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames","volume":"20","author":"Vergis","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0145","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0928-8244(03)00366-3","article-title":"Induction of opsonic antibodies to the gamma-d-glutamic acid capsule of Bacillus anthracis by immunization with a synthetic peptide-carrier protein conjugate","volume":"40","author":"Wang","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1476-9433-4-4","article-title":"Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin","volume":"4","author":"Wang","year":"2005","journal-title":"Med. Immunol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0155","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s11274-011-0729-z","article-title":"Surface display of the 20-kDa N-terminal fragment of anthrax protective antigen based on attenuated recombinant Bacillus anthracis","volume":"27","author":"Wang","year":"2011","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1099\/0022-1317-51-10-821","article-title":"In vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody","volume":"51","author":"Welkos","year":"2002","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.molimm.2014.01.012_bib0165","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1099\/00221287-147-6-1677","article-title":"The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores","volume":"147","author":"Welkos","year":"2001","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.molimm.2014.01.012_bib0170","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/JB.186.2.566-569.2004","article-title":"Surface layer protein EA1 is not a component of Bacillus anthracis spores but is a persistent contaminant in spore preparations","volume":"186","author":"Williams","year":"2004","journal-title":"J. Bacteriol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014000224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014000224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T06:16:49Z","timestamp":1597472209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589014000224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0161589014000224"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2014.01.012","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective antigen and extractable antigen 1 based chimeric protein confers protection against Bacillus anthracis in mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2014.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}